NCT00656708

Brief Summary

The purpose of this study is to determine whether Kerlix AMD gauze will decrease the incidence of healthcare associated infections in burn patients. Kerlix AMD gauze will be applied to all patients with open wounds admitted to the burn unit during the prospective portion of the study. All consenting patients will be assessed for hospital associated infections and outcomes. We hypothesis that burn patients will have a decreased number of hospital associated infections compared to historical controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 11, 2008

Completed
4 months until next milestone

Study Start

First participant enrolled

August 1, 2008

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
Last Updated

October 12, 2018

Status Verified

August 1, 2009

Enrollment Period

10 months

First QC Date

April 7, 2008

Last Update Submit

October 9, 2018

Conditions

Keywords

BurnsWoundsHealthcare associated infectionsMRSAVRE

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint is the incidence of healthcare associated infections in the study of the acute burn population when using Kerlix AMD gauze as compared to that in matched historical controls when using standard, non-impregnated gauze.

    2 years

Secondary Outcomes (7)

  • Compare the incidence of wound infections between the acute burn study patients and the matched historical control patients.

    2 years

  • Compare the incidence of healthcare associated infections in the unit when using Kerlix AMD to the previous year using standard gauze. Epidemiology infection rates will be used to compare the incidence of infections.

    2 years

  • Compare the presence of pathogenic organisms on weekly wound swabs between the acute burn study patients and the matched historical control patients.

    2 years

  • Compare the nasal MSSA/MRSA colonization between the acute burn study patients and the matched historical control patients.

    2 years

  • Compare the incidence of rectal VRE colonization between the acute burn study patients and the matched historical control patients.

    2 years

  • +2 more secondary outcomes

Study Arms (1)

PB

EXPERIMENTAL

All patients admitted to the burn unit during the prospective portion (interventional portion) of the study who have open wounds will have Kerlix AMD applied to their wounds; only those patients consenting to the study will have data abstracted.

Other: Kerlix AMD gauze

Interventions

Use Kerlix AMD gauze as the wound dressing for the entire burn unit

Also known as: Kerlix Gauze
PB

Eligibility Criteria

Age1 Year+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • admitted to the burn unit with a burn or open wound and anticipated to have a length of stay greater than 48 hours

You may not qualify if:

  • pregnant or nursing women
  • wound is considered unsuitable for study dressings as determined by primary physician
  • use of Dakin's solution on wound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Iowa Hospitals & Clinics

Iowa City, Iowa, 52242, United States

Location

Related Publications (10)

  • Appelgren P, Bjornhagen V, Bragderyd K, Jonsson CE, Ransjo U. A prospective study of infections in burn patients. Burns. 2002 Feb;28(1):39-46. doi: 10.1016/s0305-4179(01)00070-5.

    PMID: 11834328BACKGROUND
  • Taylor GD, Kibsey P, Kirkland T, Burroughs E, Tredget E. Predominance of staphylococcal organisms in infections occurring in a burns intensive care unit. Burns. 1992 Aug;18(4):332-5. doi: 10.1016/0305-4179(92)90158-q.

    PMID: 1418512BACKGROUND
  • Wibbenmeyer L, Danks R, Faucher L, Amelon M, Latenser B, Kealey GP, Herwaldt LA. Prospective analysis of nosocomial infection rates, antibiotic use, and patterns of resistance in a burn population. J Burn Care Res. 2006 Mar-Apr;27(2):152-60. doi: 10.1097/01.BCR.0000203359.32756.F7.

    PMID: 16566558BACKGROUND
  • Wurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M. Nosocomial infections in a burn intensive care unit. Burns. 1995 May;21(3):181-4. doi: 10.1016/0305-4179(95)80005-9.

    PMID: 7794498BACKGROUND
  • National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. Am J Infect Control. 2001 Dec;29(6):404-21. doi: 10.1067/mic.2001.119952. No abstract available.

    PMID: 11743489BACKGROUND
  • Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control. 2005 Nov;33(9):501-9. doi: 10.1016/j.ajic.2005.04.246.

    PMID: 16260325BACKGROUND
  • Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis. 2003 Aug 15;37(4):543-50. doi: 10.1086/376993. Epub 2003 Jul 30.

    PMID: 12905139BACKGROUND
  • Motta GJ, Milne CT, Corbett LQ. Impact of antimicrobial gauze on bacterial colonies in wounds that require packing. Ostomy Wound Manage. 2004 Aug;50(8):48-62.

    PMID: 15356368BACKGROUND
  • Motta GJ, Trigilia D. The effect of an antimicrobial drain sponge dressing on specific bacterial isolates at tracheostomy sites. Ostomy Wound Manage. 2005 Jan;51(1):60-2, 64-6.

    PMID: 15695836BACKGROUND
  • Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988 Jun;16(3):128-40. doi: 10.1016/0196-6553(88)90053-3.

    PMID: 2841893BACKGROUND

MeSH Terms

Conditions

BurnsWounds and InjuriesCross Infection

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Lucy A Wibbenmeyer, MD

    The University of Iowa Hospitals & Clinics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

April 7, 2008

First Posted

April 11, 2008

Study Start

August 1, 2008

Primary Completion

June 1, 2009

Study Completion

January 1, 2011

Last Updated

October 12, 2018

Record last verified: 2009-08

Data Sharing

IPD Sharing
Will not share

Locations